Recent Articles from GlobeNewswire

Bombardier Announces Pricing of its New Issuance of 5.875% Senior Notes due 2035
MONTRÉAL, May 04, 2026 (GLOBE NEWSWIRE) -- Bombardier Inc. (“Bombardier”) today announced that it has successfully priced its offering of US$500,000,000 aggregate principal amount of new Senior Notes due 2035 (the “New Notes”). The New Notes will carry a coupon of 5.875% per annum and will be sold at par. The issuance of the New Notes is expected to close on or about May 15, 2026, subject to customary closing conditions.
By Bombardier Inc. · Via GlobeNewswire · May 4, 2026
Pennant Announces First Quarter 2026 Earnings Release and Call
EAGLE, Idaho, May 04, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it expects to issue its first quarter 2026 financial results on Wednesday, May 6, 2026.
By Pennant Group, Inc. · Via GlobeNewswire · May 4, 2026
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages New Era Energy & Digital, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NUAI
NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · May 4, 2026
Magna Announces 2026 Annual Meeting Results
AURORA, Ontario, May 04, 2026 (GLOBE NEWSWIRE) -- Magna International Inc. (TSX: MG; NYSE: MGA) today announced voting results from its 2026 annual meeting of shareholders held on May 4, 2026. A total of 218,968,145 Common Shares or 79.21% of our issued and outstanding Common Shares were represented in person or by proxy at the meeting. Shareholders voted in favour of each item of business, as follows:
By Magna International Inc. · Via GlobeNewswire · May 4, 2026
Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Medpace Holdings, Inc. and Encourages Investors to Contact the Firm Before June 5th
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Medpace (MEDP) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · May 4, 2026
NEKTAR THERAPEUTICS CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Nektar Therapeutics and Encourages Investors to Contact the Firm Before May 5th
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nektar (NKTR) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · May 4, 2026
EOS ENERGY DEADLINE TOMORROW: Bragar Eagel & Squire, P.C. Reminds Eos Energy Enterprises, Inc. (NASDAQ:EOSE) Investors to Contact the Firm Regarding Their Rights Before May 5th
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Eos (EOSE) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · May 4, 2026
Roblox Investigation Initiated: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Roblox Corporation - RBLX
NEW YORK and NEW ORLEANS , May 04, 2026 (GLOBE NEWSWIRE) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), is investigating claims on behalf of investors of Roblox Corporation (NYSE: RBLX). Such investors are advised to contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit us at https://www.ksfcounsel.com/cases/nyse-rblx/ to learn more.
By Kahn Swick & Foti, LLC · Via GlobeNewswire · May 4, 2026
BABCOCK & WILCOX CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urges Babcock & Wilcox Enterprises, Inc. Investors with Large Losses to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In B&W (BW) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · May 4, 2026
GLOBANT INVESTOR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Globant S.A. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Globant (GLOB) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · May 4, 2026
Ballad Health invests $15 million to expand robotic-assisted surgery, earns national accreditation for quality and surgical excellence
JOHNSON CITY, Tenn., May 04, 2026 (GLOBE NEWSWIRE) -- Ballad Health was awarded Network of Excellence accreditation in robotic surgery by Surgical Review Corporation (SRC), honoring systemwide excellence in patient safety, surgical outcomes and clinical consistency. The national recognition coincides with a $15 million investment to expand robotic-assisted surgery across the region, bringing the program to additional rural hospitals. Ballad Health also recognized multiple surgeons who have achieved SRC Master Surgeon accreditation, underscoring a sustained commitment to the highest standards of surgical quality across the Appalachian Highlands.
By Ballad Health · Via GlobeNewswire · May 4, 2026
POET CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against POET Technologies, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In POET To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · May 4, 2026
SES AI LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against SES AI Corporation and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In SES To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · May 4, 2026
VERI INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Veritone, Inc.
NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Veritone, Inc. (“Veritone” or the “Company”) (NASDAQ:VERI) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices.
By Kirby McInerney LLP · Via GlobeNewswire · May 4, 2026
McEwen Files NI 43-101 Technical Report for the Tartan Mine Project in Manitoba
TORONTO, May 04, 2026 (GLOBE NEWSWIRE) -- McEwen Inc. (NYSE/TSX: MUX) (“McEwen” or the “Company”) is pleased to announce that it has filed on SEDAR+ an independent technical report prepared in accordance with National Instrument 43-101 - Standards of Disclosure for Mineral Projects (“NI 43-101”) for the Tartan Mine Project, located near Flin Flon, Manitoba.
By McEwen Inc. · Via GlobeNewswire · May 4, 2026
SOLENO THERAPEUTICS CLASS ACTION DEADLINE TOMORROW: Bragar Eagel & Squire, P.C. Urges Soleno Therapeutics, Inc. Investors with Significant Losses to Contact the Firm Before May 5th Lead Plaintiff Deadline
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Soleno (SLNO) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · May 4, 2026
New NCBE Report Confirms NextGen Uniform Bar Exam Ready for Launch
Analysis Confirms Stable Scoring, Strong Platform Performance, and Rigorous Assessment Standards
Canon and Local Organizations Celebrate Earth Day 2026 with Community Recycling Drives at Melville Headquarters
Melville, NY, May 04, 2026 (GLOBE NEWSWIRE) -- Canon U.S.A., Inc., a leader in digital imaging solutions, recently hosted an Earth Day event for employees at its corporate headquarters. Bringing together several organizations which the company collaborates with on corporate social responsibility initiatives, Canon’s event focused on recycling unwanted items and learning more about sustainable practices, emphasizing its commitment to social and environmental responsibility through its Kyosei philosophy.
By Canon U.S.A., Inc. · Via GlobeNewswire · May 4, 2026
Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study
PARIS and CAMBRIDGE, Mass., May 04, 2026 (GLOBE NEWSWIRE) --  NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer and other major diseases, today announced FDA acceptance of a protocol amendment to the ongoing pivotal NANORAY-312 study.
By Nanobiotix S.A. · Via GlobeNewswire · May 4, 2026
Constellation Brands Prices Offering of Senior Notes
ROCHESTER, N.Y., May 04, 2026 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today that it priced the public offering of $500.0 million aggregate principal amount of 4.850% Senior Notes due 2031 (the "notes") for a public offering price of 99.943% of the principal amount of the notes. The notes will be senior obligations that rank equally with all of Constellation’s other senior unsecured indebtedness.
By Constellation Brands, Inc. · Via GlobeNewswire · May 4, 2026
Ero Copper Reports First Quarter 2026 Operating and Financial Results
(all amounts in US dollars, unless otherwise noted)
By Ero Copper Corp. · Via GlobeNewswire · May 4, 2026
Owens-Brockway Glass Container Inc. Announces Pricing of Senior Notes Offering
PERRYSBURG, Ohio, May 04, 2026 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE
Osisko Development Appoints Vice President, Construction Contracting and Commercial
MONTREAL, May 04, 2026 (GLOBE NEWSWIRE) -- Osisko Development Corp. (NYSE: ODV, TSXV: ODV) ("Osisko Development" or the "Company") is pleased to announce the appointment of Ms. Sarah MacDonald as Vice President, Construction Contracting and Commercial, effective immediately.
By Osisko Development Corp. · Via GlobeNewswire · May 4, 2026
Aptera Motors to Present at the Emerging Growth Conference on May 6, 2026
Aptera Motors invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation on the Emerging Growth Conference
By Aptera Motors Corp · Via GlobeNewswire · May 4, 2026
New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC
MELBOURNE, Australia and INDIANAPOLIS, May 05, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces the publication of a new independent analysis of Phase 3 ZIRCON trial data in European Urology1, demonstrating that TLX250-Px (Zircaix®2, 89Zr-girentuximab) PET/CT3 imaging may be highly predictive of renal malignancy across all subtypes, not limited to clear cell renal cell carcinoma (ccRCC).
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that effective May 1, 2026, the Compensation Committee of Tango Therapeutics' Board of Directors granted (i) a non-qualified stock option to purchase an aggregate of 240,000 shares of its common stock and 40,000 restricted stock units (RSUs) to Matthew Gall, the Company’s Chief Financial Officer and (ii) a non-qualified stock option to purchase an aggregate of 199,650 shares of its common stock and 33,250 RSUs to a new employee, under Tango Therapeutics' 2023 Inducement Plan.
Cellectis to Report First Quarter Financial Results on May 11, 2026
NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it will report financial results for the first quarter 2026 ending March 31, 2026 on Monday, May 11, 2026 after the close of the US market.
By Cellectis Inc. · Via GlobeNewswire · May 4, 2026
Cabot Corporation Board Increases Dividend
BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- On May 1, 2026, the Board of Directors of Cabot Corporation (NYSE: CBT) declared a quarterly dividend of $0.4725 per share, an increase of 5% compared to the current quarterly dividend of $0.45 per share, payable on all outstanding shares of the Corporation’s common stock. The dividend is payable on June 12, 2026, to stockholders of record of such common stock at the close of business on May 29, 2026.
By Cabot Corporation · Via GlobeNewswire · May 4, 2026
Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
DEER PARK, Ill., May 04, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report first quarter 2026 financial results on Thursday, May 14, 2026. Management will host a conference call and live audio webcast to discuss the results at 4:30 p.m. ET (3:30 p.m. CT).
By Eton Pharmaceuticals · Via GlobeNewswire · May 4, 2026
Microvast Schedules First Quarter Earnings Call
STAFFORD, Texas, May 04, 2026 (GLOBE NEWSWIRE) -- Microvast Holdings, Inc. (NASDAQ: MVST), (“Microvast” or the “Company”), a global leader in advanced battery technologies, will issue a press release reporting its consolidated financial results for the first quarter of 2026 after market close on Monday, May 11, 2026.
By Microvast Holdings, Inc. · Via GlobeNewswire · May 4, 2026
TOP Financial Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Hong Kong, China, May 04, 2026 (GLOBE NEWSWIRE) -- TOP Financial Group Limited (the "Company") (NASDAQ: TOP), a fast-growing online brokerage firm located in Hong Kong specializing in the trading of local and foreign equities, futures, options products and other financial services, today announced that on April 28, 2026, the Company received a notice from the staff of the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC ("Nasdaq") stating that for the last 30 consecutive business days, the closing bid price of the Company’s Class A ordinary shares, par value US$0.001 per share (the “Class A Ordinary Shares”) was below the minimum bid price of US$1.00 per share requirement set forth in Nasdaq Listing Rule 5550(a)(2). The Nasdaq notification letter has no current effect on the listing or trading of the Company’s Class A Ordinary Shares on Nasdaq.
Jushi Holdings Inc. to Report First Quarter 2026 Financial Results on May 12, 2026
BOCA RATON, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first quarter ended March 31, 2026, after the market closes on Tuesday, May 12, 2026.
By Jushi Holdings Inc. · Via GlobeNewswire · May 4, 2026
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, May 04, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company granted stock options to five new employees to purchase an aggregate of 154,700 shares of the Company's common stock, effective as of May 1, 2026. These awards were approved by the Compensation Committee of Olema’s Board of Directors and granted under the Company's 2022 Inducement Plan as an inducement material to the new employees entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).
By Olema Oncology · Via GlobeNewswire · May 4, 2026
Teva to Present at the BofA Securities Health Care Conference
PARSIPPANY, N.J., and TEL AVIV, Israel, May 04, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Eric Hughes, Teva's EVP of Global R&D & Chief Medical Officer, will present at the BofA Securities Health Care Conference on Tuesday, May 12, 2026. The presentation will begin at 9:20 A.M. Pacific Time (12:20 P.M. Eastern Time).
BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026
Live webcast on Friday, May 8, 2026, beginning at 12:30 PM ET
By BioAge Labs, Inc. · Via GlobeNewswire · May 4, 2026
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on May 1, 2026, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 53,400 shares of Vor Bio’s common stock and restricted stock units (“RSUs”) representing the right to receive an aggregate of 11,350 shares of Vor Bio’s common stock to 6 newly hired employees. The foregoing stock options and RSUs were granted as material inducements to employment with Vor Bio in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Vor Biopharma Inc. 2023 Inducement Plan (the “Inducement Plan”).
By Vor Biopharma · Via GlobeNewswire · May 4, 2026
Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today announced that Daniel Faga, president and chief executive officer of Anaptys, is scheduled to participate in a fireside chat at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference on Wednesday, May 6, 2026. The fireside chat is scheduled to begin at 1:30pm ET.
By AnaptysBio, Inc. · Via GlobeNewswire · May 4, 2026
CooperCompanies Appoints Paul Keel to its Board of Directors
SAN RAMON, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today that its Board of Directors has appointed Paul Keel as an independent director, effective July 1, 2026. Mr. Keel has also been appointed to serve on the Audit Committee when he joins the Board.
By CooperCompanies · Via GlobeNewswire · May 4, 2026
Macerich Declares the Quarterly Dividend on Its Common Shares
SANTA MONICA, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of The Macerich Company (NYSE: MAC) declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on June 29, 2026, to stockholders of record at the close of business on June 15, 2026.
By Macerich Company · Via GlobeNewswire · May 4, 2026
Firefly Aerospace Announces First Quarter 2026 Financial Results
Completed critical milestones for Blue Ghost, successfully returned Alpha to flight, and recently selected to support the Golden Dome Space-Based Interceptor program
By Firefly Aerospace · Via GlobeNewswire · May 4, 2026
Adeia Announces CEO Paul Davis to Step Down by the Fourth Quarter of 2026; Board Launches Search Process
SAN JOSE, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA), the technology company known for developing foundational innovations that enable next-generation solutions for the semiconductor and media industries, today announced that after nearly 15 years at the company (including its predecessor companies), with the past four years serving as chief executive officer of Adeia Inc., Paul E. Davis has informed the company and the Board of Directors (the “Board”) that he intends to step down as the company’s chief executive officer and as a member of the Board to focus on his health and personal pursuits. Davis plans to stay on as the chief executive officer and Board member until such time as a successor has been named, with a target date for the search to be completed by the fourth quarter of 2026.
By Adeia Inc. · Via GlobeNewswire · May 4, 2026
Rumble Announces Timing of First Quarter 2026 Earnings Release and Conference Call
LONGBOAT KEY, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- Rumble Inc. (NASDAQ: RUM) (“Rumble” or the “Company”), the Freedom-First technology platform, today announced that it will release financial results for the fiscal quarter ended March 31, 2026 after market close on Thursday, May 14, 2026. The Company will host a conference call on the same day at 5:00 p.m. Eastern Time.
By Rumble, Inc. · Via GlobeNewswire · May 4, 2026
Adeia Announces First Quarter 2026 Financial Results
Signed new license agreements with AMD and MicrosoftGenerated $58 million in cash from operations and achieved 60% adjusted EBITDA marginPaid down debt by $28 million bringing our outstanding balance to less than $400 million
By Adeia Inc. · Via GlobeNewswire · May 4, 2026
onsemi Reports First Quarter 2026 Results
Year-over-year operating income growth outpaces revenue growth by 2x
By onsemi · Via GlobeNewswire · May 4, 2026
James River Announces First Quarter 2026 Results
CHAPEL HILL, N.C., May 04, 2026 (GLOBE NEWSWIRE) -- Chapel Hill, N.C., May 4, 2026 - James River Group Holdings, Inc. ("James River" or the "Company") (NASDAQ: JRVR) today reported the following results for the first quarter of 2026 as compared to the same period in 2025:
Shimmick Corporation to Announce First Quarter 2026 Financial Results on May 14, 2026
IRVINE, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- Shimmick Corporation (“Shimmick”) (Nasdaq: SHIM), a national leader in complex infrastructure solutions, today announced that the company will release its first quarter 2026 financial results after market close on Thursday, May 14, 2026.
By Shimmick Corporation · Via GlobeNewswire · May 4, 2026
Silvaco Announces Participation at Upcoming Investor Conferences
SANTA CLARA, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. (Nasdaq: SVCO) (“Company”, “Silvaco”), a provider of TCAD, EDA software, and SIP solutions that enable innovative semiconductor design and digital twin modeling through AI software and automation, today announced that Chief Executive Officer, Walden Rhines, and Chief Financial Officer, Chris Zegeralli, will be participating at upcoming investor conferences. Details for each event are as follows:
By Silvaco · Via GlobeNewswire · May 4, 2026
ThredUp Announces First Quarter 2026 Results
OAKLAND, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- ThredUp Inc. (Nasdaq: TDUP, LTSE: TDUP), one of the largest online resale platforms for apparel, shoes, and accessories, announced today its financial results for the first quarter ended March 31, 2026 and updated full year 2026 financial outlook.
By ThredUp Inc. · Via GlobeNewswire · May 4, 2026
EverQuote Announces First Quarter 2026 Financial Results
CAMBRIDGE, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- EverQuote, Inc. (Nasdaq: EVER), a leading provider of growth solutions for property and casualty, or P&C, insurance providers, today announced financial results for the first quarter ended March 31, 2026.
By EverQuote, Inc. · Via GlobeNewswire · May 4, 2026
Clip Money Inc. Announces Amendment of Unsecured Convertible Notes
TORONTO, May 04, 2026 (GLOBE NEWSWIRE) -- Clip Money Inc. (TSX-V: CLIP) (“Clip Money” or the “Company”), a company that operates a multi-bank self-service deposit system for businesses, is pleased to announce that, in support of strengthening its liquidity and maximizing working capital for future growth, it will (i) extend the maturity date (the “Maturity Date”) of the first tranche of the previously issued unsecured convertible notes dated May 4, 2023 (the “First Tranche Convertible Notes”) from May 4, 2026 to May 4, 2027 for all note holders who have consented to such extension, and (ii) offer an equivalent extension of the Maturity Date to all holders of the second tranche of the previously issued unsecured convertible notes dated June 14, 2023 (the “Second Tranche Convertible Notes” and, together with the First Tranche Convertible Notes, the “Convertible Notes”) from June 14, 2026 to June 14, 2027.
By Clip Money Inc · Via GlobeNewswire · May 4, 2026
NFT LTD Files Annual Report on Form 20-F for Fiscal Year 2025
Hong Kong, May 04, 2026 (GLOBE NEWSWIRE) -- NFT Ltd ("NFT" or the "Company") (NYSE American: MI), an emerging online trading platform operator of international art and collectibles, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission ("SEC") on May 1, 2026. The annual report can be accessed on the SEC's website at http://www.sec.gov as well as on the Company's investor relations website at https://www.nftoeo.com/investor.html.
By NFT Ltd · Via GlobeNewswire · May 4, 2026
Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital
$55 million funded at closing to repay existing loan facility
CoinShares ETPs Now Available on Bourse Direct as France Opens Retail Access to Regulated Crypto Products
4 May 2026 | SAINT HELIER, Jersey | CoinShares PLC ("CoinShares" or "the Group") (Nasdaq: CSHR), a global leading asset manager specializing in digital assets today announced that 5 products of its range of physically-backed crypto Exchange-Traded Products (ETPs) are now available to retail investors through Bourse Direct, one of France's leading online brokerage platforms.
By CoinShares PLC · Via GlobeNewswire · May 4, 2026
ORIC® Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Updates
Announced selection of rinzimetostat RP3D in combination with darolutamide for Himalayas-1 Phase 3 global registrational trial in post-abiraterone mCRPC, expected to initiate in 1H 2026
By ORIC Pharmaceuticals · Via GlobeNewswire · May 4, 2026
Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, today announced the initiation of a Phase 1b clinical trial of AKY-25191 in patients with metastatic castration-resistant prostate cancer (mCRPC). The mCRPC-dedicated Phase 1b trial is part of Aktis’ clinical development strategy to develop AKY-2519 broadly in B7-H3 expressing tumors. Aktis plans to initiate a Phase 1b basket trial in lung, colorectal, and other high B7-H3 expressing solid tumors in the second half of 2026.
By Aktis Oncology Inc. · Via GlobeNewswire · May 4, 2026
Option Care Health to Participate in the Bank of America Health Care Conference
BANNOCKBURN, Ill., May 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the Bank of America Health Care Conference, being held in Las Vegas, on Tuesday, May 12, 2026, including a fireside chat at 10:40am PT/1:40pm ET. The webcast will be available online at https://investors.optioncarehealth.com.
By Option Care Health, Inc. · Via GlobeNewswire · May 4, 2026
Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes
MALVERN, Pa., May 04, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced its intention to offer, subject to market conditions and other factors, $115 million aggregate principal amount of Convertible Senior Notes due 2034 (the “notes”) in a private offering (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Ocugen also expects to grant the initial purchaser of the notes a 13-day option to purchase up to an additional $15 million aggregate principal amount of the notes. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
By Ocugen · Via GlobeNewswire · May 4, 2026
Biodesix Announces First Quarter 2026 Results and Highlights
Delivered $25.6 million in revenue representing 42% growth in Q1 2026;
By Biodesix, Inc. · Via GlobeNewswire · May 4, 2026
Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
CAMBRIDGE, Mass. and COPENHAGEN, Denmark, May 04, 2026 (GLOBE NEWSWIRE) -- Hemab Therapeutics Holdings, Inc. (Nasdaq: COAG), a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience, today announced the closing of its initial public offering of 19,262,500 shares of its common stock at a public offering price of $18.00 per share, including 2,512,500 additional shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares. All of the shares of common stock were sold by Hemab. Hemab’s common stock began trading on the Nasdaq Global Select Market on Friday, May 1, 2026 under the ticker symbol “COAG.” The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Hemab, were approximately $346.7 million.
By Hemab Therapeutics, Inc. · Via GlobeNewswire · May 4, 2026
FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring
HOUSTON, May 04, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced compelling preclinical results suggesting that topical treatment with human dermal fibroblast (HDF) spheroids may reprogram the burn wound environment by dampening harmful inflammation, reshaping immune cell behavior, and reducing markers of scar-forming activity, within just eight days of injury.
By FibroBiologics, Inc. · Via GlobeNewswire · May 4, 2026
Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference
BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced it will report its financial results for the first quarter ended March 31, 2026, and provide a corporate update before the financial markets open on Thursday, May 7, 2026.
Senseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
GERMANTOWN, Md., May 04, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the design, development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced the closing of its previously announced underwritten public offering of $92 million of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants. Senseonics sold 10,400,000 shares of its common stock, which includes the full exercise of the underwriters’ option to purchase 2,400,000 additional shares of common stock, and 8,000,000 pre-funded warrants. The shares of common stock were sold at a price to the public of $5.00 per share and the pre-funded warrants were sold at a purchase price of $4.999 per share, which equals the public offering price per share of the common stock less the $0.001 exercise price per share of each pre-funded warrant. The gross proceeds to Senseonics from the offering were approximately $92.0 million, before deducting underwriting discounts and commissions and other offering expenses payable by Senseonics.
By Senseonics Holdings, Inc. · Via GlobeNewswire · May 4, 2026
Visionary Holdings Inc. Announces Receipt of Nasdaq Delisting Determination Letter Related to Delinquent Listing Fees
TORONTO, May 04, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (the “Company” or “Visionary”) today announced that it received a staff determination letter from The Nasdaq Stock Market LLC (“Nasdaq”) on April 29, 2026, notifying the Company that it was not in compliance with Nasdaq Listing Rule 5250(f) due to delinquent listing fees and that Nasdaq had determined to delist the Company’s securities unless the Company timely requested a hearing before the Nasdaq Hearings Panel.
By Visionary Holdings Inc. · Via GlobeNewswire · May 4, 2026
JOBSOHIO, AILERON EXPAND ELIGIBILITY FOR SMALL BUSINESS ACADEMY
Building on two years of impact across Ohio’s small business community, the program opens its doors wider for Cohort 3
By JobsOhio · Via GlobeNewswire · May 4, 2026
Tim Lamb Group Brokers the Sale of Friendship Ford of Lenoir in North Carolina to CarHeroes
Columbus, OH, May 04, 2026 (GLOBE NEWSWIRE) -- The Tim Lamb Group,  the largest auto dealership sales and acquisitions firm in North America, is pleased to announce it has represented the seller, Friendship Automotive, in the successful sale of Friendship Ford of Lenoir. The 25,258 square-foot dealership, located at 515 Wilkesboro Blvd. NE., in Lenoir, North Carolina has been renamed CarHeroes Ford, and was purchased by CarHeroes President, Matthew Nunlist.
By Tim Lamb Group · Via GlobeNewswire · May 4, 2026
HyOrc Provides Indicative Methanol Production Cost Range and Commercial Positioning Following Technology Validation
HOUSTON, May 04, 2026 (GLOBE NEWSWIRE) -- HyOrc Corporation (OTCQB: HYOR) today shared an update on the commercial positioning of its waste-to-methanol platform following the Company’s recently announced independent validation by Bureau Veritas.
By HyOrc Corporation · Via GlobeNewswire · May 4, 2026
Providence Saint John’s Health Center Reinforces its Commitment to Maternal and Newborn Care Through Newly Named Maria Shriver Labor, Delivery and Family Wellness Unit
Newly named labor, delivery and family wellness unit reflects a holistic, family-centered approach
Gabb Music Named a 2026 NAPPA Awards Winner
Safer music streaming for kids recognized by the National Parenting Product Awards for giving kids the music they love — without the content parents worry about
By Gabb Wireless Inc. · Via GlobeNewswire · May 4, 2026
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
EASTON, Md., May 04, 2026 (GLOBE NEWSWIRE) -- TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), a leading owner and operator of vertically integrated digital infrastructure, today announced that members of senior management will participate in the following upcoming conferences and events:
By TeraWulf Inc. · Via GlobeNewswire · May 4, 2026
Billor Launches Billor Driver, the Mobile Platform Powering the Truck Driver Journey
A mobile platform that unifies the entire truck driver journey — from first application to daily operations
By Billor Holding LLC · Via GlobeNewswire · May 4, 2026
CRN Recognizes 11 Employees at Climb Channel Solutions on the 2026 Women of the Channel List and Names Climb’s Chief Marketing Officer as one of the 2026 Women of the Channel Power 100
This recognition reinforces Climb’s role in advancing innovation, leadership, and collaboration in the channel
By Climb Channel Solutions · Via GlobeNewswire · May 4, 2026
Roadzen Announces Pricing of $8 Million Registered Direct Offering of Ordinary Shares
NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN) (“Roadzen” or the “Company”), a global leader in AI at the convergence of insurance and mobility, today announced that it has entered into a securities purchase agreement with institutional investors for the purchase and sale of 4,705,870 ordinary shares at an offering price of $1.70 per share, in a registered direct offering (the “Offering”).
By Roadzen Inc. · Via GlobeNewswire · May 4, 2026
Four Tree Island Advisory Urges Special Committee of DoubleDown Interactive to Reject Controlling Shareholder DoubleU Games’ Inadequate Takeover Proposal
Believes $11.25 per ADS Significantly Undervalues the Company
Wittichen Supply Strengthens Alabama Presence with New Madison Location
ATLANTA, May 04, 2026 (GLOBE NEWSWIRE) -- Wittichen Supply, a trusted leader in HVAC/R (Heating, Ventilation, Air Conditioning, and Refrigeration) distribution and subsidiary of Heritage Distribution Holdings, has announced the opening of its newest branch in Madison, Alabama. This addition underscores the company’s ongoing investment in growth and its commitment to supporting customers with reliable products and high-quality service.
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages POET Technologies Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – POET
NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · May 4, 2026